Ask AI
ProCE Banner Activity

Expert Approaches for Drug-Resistant Acinetobacter Infections: The ABCs of HAP and VAP

Slideset

Download these slides to crack the code for timely diagnosis and treatment initiation for multidrug-resistant and extensively drug–resistant Acinetobacter baumannii–calcoaceticus and learn how to integrate the latest developments and data into your clinical practice. 

Released: February 19, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Innoviva Specialty Therapeutics, Inc.

Innoviva Specialty Therapeutics, Inc

Target Audience

This activity is intended for clinical specialists, including physicians and clinical pharmacists, and other healthcare professionals who design therapeutic regimens for patients with Acinetobacter baumannii-calcoaceticus complex infections.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Update strategies for timely identification of ABC infections that are not adequately covered by empiric therapy.

  • Select antibiotics to optimize safety and efficacy in the treatment of HAP and VAP caused by CRAB with diverse resistance mechanisms.

  • Design evidence-based antibiotic regimens for complex patients with ABC infections.